<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41230537</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0920-9069</ISSN><JournalIssue CitedMedium="Print"><Volume>77</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Cytotechnology</Title><ISOAbbreviation>Cytotechnology</ISOAbbreviation></Journal><ArticleTitle>MAP6D1 Silencing alleviates high glucose-induced injury of trophoblast cells during gestational diabetes mellitus.</ArticleTitle><Pagination><StartPage>193</StartPage><MedlinePgn>193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10616-025-00866-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The high glucose (HG) levels in the body of a patient with gestational diabetes mellitus (GDM) constantly stimulate the trophoblast cells, leading to impaired development of the placenta thus affecting the development of the embryo. Previous analyses have indicated that the expression of microtubule-associated protein 6 domain containing 1 (MAP6D1) was lower in placental tissues of healthy pregnant women than that in GDM patients, but its specific effects and potential molecular mechanisms have not been elucidated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">HTR-8/SVneo cells were stimulated using HG to mimic the stimulation of trophoblast cells by the high glucose environment in vivo, and MAP6D1 expression was inhibited by transfection of MAP6D1 small interfering RNA (siRNA). Subsequently, cell proliferation and apoptosis levels were detected by methylthiazolyldiphenyl-tetrazolium bromide (MTT) and flow cytometry (FCM). Cell metastatic capacity was assessed by cell scratch assay and Transwell analysis. Enzyme linked immunosorbent assay (ELISA) was used to analyze the level of cellular inflammatory response. In addition, the degree of cellular oxidative stress was assessed by malondialdehyde (MDA), superoxide dismutase (SOD), and catalase (CAT) levels as well as ROS fluorescence intensity. Western blot assay was used to analyze p38 MAPK pathway changes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">HG induced elevated MAP6D1 expression in HTR-8/SVneo cells, inhibited cell viability and metastatic ability, and promoted apoptosis, while HG stimulation was able to promote cellular inflammatory responses and oxidative stress levels. In addition, HG treatment promoted the level of p38 MAPK protein phosphorylation in HTR-8/SVneo cells. However, inhibition of MAP6D1 expression was able to reverse the above results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Inhibition of MAP6D1 expression ameliorated trophoblast cell injury induced by HG stimulation, providing a potential novel target for the diagnosis and treatment of GDM.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The online version contains supplementary material available at 10.1007/s10616-025-00866-9.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Nature B.V. 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xingmei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Heilongjiang Provincial Key Laboratory of Food &amp; Medicine Homology and Metabolic Disease Prevention, Qiqihar, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Su</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jin'e</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Qiqihar Medical University, No. 333 Bukui North Street, Qiqihar, 166003 China.</Affiliation><Identifier Source="ROR">https://ror.org/01kzgyz42</Identifier><Identifier Source="GRID">grid.412613.3</Identifier><Identifier Source="ISNI">0000 0004 1808 3289</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Meiqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Gynecology, the Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000 China.</Affiliation><Identifier Source="ROR">https://ror.org/02g9jg318</Identifier><Identifier Source="GRID">grid.479689.d</Identifier><Identifier Source="ISNI">0000 0005 0269 9430</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Hongbo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Qiqihar Medical University, No. 333 Bukui North Street, Qiqihar, 166003 China.</Affiliation><Identifier Source="ROR">https://ror.org/01kzgyz42</Identifier><Identifier Source="GRID">grid.412613.3</Identifier><Identifier Source="ISNI">0000 0004 1808 3289</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Heilongjiang Provincial Key Laboratory of Food &amp; Medicine Homology and Metabolic Disease Prevention, Qiqihar, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cytotechnology</MedlineTA><NlmUniqueID>8807027</NlmUniqueID><ISSNLinking>0920-9069</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">HTR-8/SVneo cells</Keyword><Keyword MajorTopicYN="N">High glucose</Keyword><Keyword MajorTopicYN="N">MAP6D1</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>4</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41230537</ArticleId><ArticleId IdType="pmc">PMC12602834</ArticleId><ArticleId IdType="doi">10.1007/s10616-025-00866-9</ArticleId><ArticleId IdType="pii">866</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alejandro EU, Mamerto TP, Chung G et al (2020) Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. Int J Mol Sci 21(14):5003</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404253</ArticleId><ArticleId IdType="pubmed">32679915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalla S, Chaudhary K, Kumar R et al (2017) Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Sci Rep 7:44997</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5368637</ArticleId><ArticleId IdType="pubmed">28349958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao HM, Wan Z, Wu Y, Wang HY, Guan C (2019) Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer. Medicine 98(30):e16534</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6708735</ArticleId><ArticleId IdType="pubmed">31348270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli M, Diamanti K, Pan G, Dabrowski MJ, Komorowski J, Wadelius C (2021) A non-coding cancer mutation disrupting an HNF4&#x3b1; binding motif affects an enhancer regulating genes associated to the progression of liver cancer. Exp Oncol 43(1):2&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">33785712</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui SS, Zhang P, Sun L et al (2023) Mucin1 induced trophoblast dysfunction in gestational diabetes mellitus via Wnt/&#x3b2;-catenin pathway. Biol Res 56(1):48</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10463356</ArticleId><ArticleId IdType="pubmed">37608294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuveillier C, Boulan B, Ravanello C, Denarier E, Deloulme JC, Gory-Faur&#xe9; S, Delphin C, Bosc C, Arnal I, Andrieux A (2021) Beyond neuronal microtubule stabilization: MAP6 and CRMPS, two converging stories. Front Mol Neurosci 14:665693</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8131560</ArticleId><ArticleId IdType="pubmed">34025352</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher JJ, Vanderpeet CL, Bartho LA et al (2021) Mitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus. J Physiol 599(4):1291&#x2013;1305</Citation><ArticleIdList><ArticleId IdType="pubmed">33135816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gory-Faur&#xe9; S, Windscheid V, Bosc C et al (2006) Stop-like protein 21 is a novel member of the STOP family, revealing a golgi localization of STOP proteins. J Biol Chem 281(38):28387&#x2013;28396</Citation><ArticleIdList><ArticleId IdType="pubmed">16837464</ArticleId></ArticleIdList></Reference><Reference><Citation>Gory-Faur&#xe9; S, Windscheid V, Brocard J et al (2014) Non-microtubular localizations of microtubule-associated protein 6 (MAP6). PLoS ONE 9(12):e114905 Published 2014 Dec 19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272302</ArticleId><ArticleId IdType="pubmed">25526643</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlev A, Aricha-Tamir B, Shaco-Levy R, Tarnovscki T, Bashan N, Rudich A, Sheiner E, Press F, Wiznitzer A (2014) Macrophage infiltration and stress-signaling in omental and subcutaneous adipose tissue in diabetic pregnancies. J Matern Fetal Neonatal Med 27(12):1189&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pubmed">24111719</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Liu Y, Sun M (2021) Nesfatin-1 alleviates high glucose/high lipid-induced injury of trophoblast cells during gestational diabetes mellitus. Bioengineered 12(2):12789&#x2013;12799</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810041</ArticleId><ArticleId IdType="pubmed">34895049</ArticleId></ArticleIdList></Reference><Reference><Citation>Immanuel J, Simmons D (2017) Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diab Rep 17(11):115</Citation><ArticleIdList><ArticleId IdType="pubmed">28971305</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Gao H, Zhou W, Cai H, Liao L, Wang C, Circular (2023) RNA HIPK3 facilitates ferroptosis in gestational diabetes mellitus by regulating glutathione peroxidase 4 DNA methylation. J Gene Med 25(9):e3526</Citation><ArticleIdList><ArticleId IdType="pubmed">37253602</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhang J, Liu Y (2021) Microrna-1323 serves as a biomarker in gestational diabetes mellitus and aggravates high glucose-induced inhibition of trophoblast cell viability by suppressing TP53INP1. Exp Ther Med 21(3):230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851622</ArticleId><ArticleId IdType="pubmed">33603839</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lu C (2025) SCUBE1 Promotes Gestational Diabetes Mellitus: A Bioinformatics and Experimental Investigation. Biochem Genet 63(2):1381&#x2013;1399</Citation><ArticleIdList><ArticleId IdType="pubmed">38565759</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yang X, Wang Y, Nai Y, Ji L, Zhu H, Lai R, Wang QT, Hu H, Wang L (2024) ARID1A recruits GATA2 to regulate the senescence of trophoblast cells under high-glucose condition. Placenta 158:156&#x2013;164</Citation><ArticleIdList><ArticleId IdType="pubmed">39490111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzon AR, Moreli JB, de Macedo Melo R et al (2021) Stromal Cell-Derived factor (SDF) 2 and the Endoplasmic reticulum stress response of trophoblast cells in gestational diabetes mellitus and in vitro hyperglycaemic condition. Curr Vasc Pharmacol 19(2):201&#x2013;209</Citation><ArticleIdList><ArticleId IdType="pubmed">32504504</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng HY, Li MQ, Li HP (2019) MiR-137 restricts the viability and migration of HTR-8/SVneo cells by downregulating FNDC5 in gestational diabetes mellitus. Curr Mol Med 19(7):494&#x2013;505</Citation><ArticleIdList><ArticleId IdType="pubmed">31109274</ArticleId></ArticleIdList></Reference><Reference><Citation>Price SAL, Moses RG (2020) Gestational diabetes mellitus and glucose sample handling. Diabetes Care 43(7):1371&#x2013;1372</Citation><ArticleIdList><ArticleId IdType="pubmed">32561615</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucedo R, Ortega-Camarillo C, Ferreira-Hermosillo A, D&#xed;az-Vel&#xe1;zquez MF, Meixueiro-Calder&#xf3;n C, Valencia-Ortega J (2023) Role of oxidative stress and inflammation in gestational diabetes mellitus. Antioxidants 12(10):1812</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10604289</ArticleId><ArticleId IdType="pubmed">37891891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokou R, Moschari E, Palioura AE et al (2024) The impact of gestational diabetes mellitus (GDM) on the development and composition of the neonatal gut microbiota: a systematic review. Microorganisms 12(8):1564</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11356352</ArticleId><ArticleId IdType="pubmed">39203408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeting A, Wong J, Murphy HR, Ross GP (2022) A clinical update on gestational diabetes mellitus. Endocr Rev 43(5):763&#x2013;793</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9512153</ArticleId><ArticleId IdType="pubmed">35041752</ArticleId></ArticleIdList></Reference><Reference><Citation>Szmuilowicz ED, Josefson JL, Metzger BE (2019) Gestational diabetes mellitus. Endocrinol Metab Clin North Am 48(3):479&#x2013;493</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7008467</ArticleId><ArticleId IdType="pubmed">31345518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MZ, Gu TW, Xu Y, Yang L, Jiang ZH, Peng LH (2021) Mechanical stretching of cells and lipid nanoparticles for nucleic acid delivery. J Control Release 339:208&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pubmed">34563590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Zou H, Zhang T et al (2024) Gestational diabetes mellitus: what can medical nutrition therapy do? Nutrients 16(8):1217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11055016</ArticleId><ArticleId IdType="pubmed">38674907</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson JM, Arthurs AL, Smith MD, Roberts CT, Jankovic-Karasoulos T (2022) High folate, perturbed one-carbon metabolism and gestational diabetes mellitus. Nutrients 14(19):3930</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9573299</ArticleId><ArticleId IdType="pubmed">36235580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Xiao B (2023) TDAG51 attenuates impaired lipid metabolism and insulin resistance in gestational diabetes mellitus through SREBP-1/ANGPTL8 pathway. Balkan Med J 40(3):175&#x2013;181</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10175879</ArticleId><ArticleId IdType="pubmed">36960944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W, Luo C, Huang J, Li C, Liu Z, Liu F (2022) Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 377:e067946</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9131781</ArticleId><ArticleId IdType="pubmed">35613728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Ye Y, Jia X, Wang P, Xiong Z, Zhu H (2025) The protective effects of Salusin-alpha against oxidative stress and inflammatory response in mice with gestational diabetes mellitus (GDM). Arch Physiol Biochem 131(3):493&#x2013;502</Citation><ArticleIdList><ArticleId IdType="pubmed">39983094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41230535</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2753-4294</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>BMJ public health</Title><ISOAbbreviation>BMJ Public Health</ISOAbbreviation></Journal><ArticleTitle>Alcohol consumption during pregnancy in Scotland following public health interventions: population-based study.</ArticleTitle><Pagination><StartPage>e003264</StartPage><MedlinePgn>e003264</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e003264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjph-2025-003264</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Alcohol consumption during pregnancy is associated with adverse maternal and perinatal outcomes, with no safe lower limit established. We evaluated the individual and cumulative impact of three alcohol-related interventions on maternal alcohol use and perinatal outcomes in Scotland.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Population-based study using Scottish National Health Service administrative linked data of all mothers giving birth in Scotland between 1 April 2013 and 31 December 2019. We investigated if alcohol consumption during pregnancy, as well as perinatal outcomes of small for gestational age (SGA), neonatal unit admission, and premature birth were affected by Public Health measures. The individual and cumulative effects of (1) Change in drink-driving legislation (5 December 2014), (2) UK Chief Medical Officers' (CMO) advice to abstain from alcohol during pregnancy (6 January 2016) and (3) Alcohol minimum unit pricing (MUP) (1 May 2018) were assessed using time series analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 346&#x2009;360 antenatal care initiates, 92.7% had alcohol consumption data. By 2019, 26.1% reported alcohol use during pregnancy, with 55.2%&#x2009;women consuming &gt;4 units per week. In women reporting alcohol use, MUP introduction showed a significant reduction in consumption by 0.59 (95% CI -0.99 to -0.18) units/week, contributing to an overall 0.69 (95% CI -0.90 to -0.48) units/week decrease following all interventions. Additionally, we observed improvements in perinatal outcomes, including reduced SGA (adjusted relative risk (adjRR) 0.88, 95%&#x2009;CI 0.85 to 0.90), and neonatal unit admission (adjRR 0.94, 95%&#x2009;CI 0.91 to 0.96), but not stillbirth (adjRR 0.87, 95%&#x2009;CI 0.74 to 1.02) or preterm birth (adjRR 1.09, 95%&#x2009;CI 1.06 to 1.13) following the implementation of these collective public health interventions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">One in four women self-reported alcohol consumption during early pregnancy. Only MUP was associated with lower consumption among pregnant women. The public health measures were collectively associated with improvement in select perinatal outcomes, highlighting the potential effectiveness of universal interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8172-4032</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Physics, NHS Greater Glasgow and Clyde, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyzayeva</LastName><ForeName>Aizhan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2981-8688</Identifier><AffiliationInfo><Affiliation>MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leyland</LastName><ForeName>Alastair</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3741-7099</Identifier><AffiliationInfo><Affiliation>MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pell</LastName><ForeName>Jill P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawlor</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at The University of Bristol, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Scott</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9099-3047</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kearns</LastName><ForeName>Rachel Joyce</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6156-6858</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Glasgow Royal Infirmary, Glasgow, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Public Health</MedlineTA><NlmUniqueID>9918697578906676</NlmUniqueID><ISSNLinking>2753-4294</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Female</Keyword><Keyword MajorTopicYN="N">Preventive Medicine</Keyword><Keyword MajorTopicYN="N">Public Health</Keyword></KeywordList><CoiStatement>All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. Outside of the submitted work, RJK is a board member and research lead for the Obstetric Anaesthetists&#x2019; Association, and declares funding from the Chief Scientist&#x2019;s Office (Scotland) for research unrelated to this paper in the last 36 months. SMN has participated in Advisory Boards and received speakers&#x2019; or consultancy fees from Access Fertility, Beckman Coulter, Ferring, Finox, Merck, MSD, Roche Diagnostics and The Fertility Partnership. SMN has declared funding from the Chief Scientist&#x2019;s Office and the National Institute of Health Research, for research unrelated to this paper in the last 36 months. All funds for these grants go to and are managed and audited by the University of Glasgow. DAL has declared funding from the National Institute of Health Research, Diabetes UK and the US National Institute of Health Research, for research unrelated to this paper in the last 36 months. All funds for these grants go to and are managed and audited by the University of Bristol. DL is a member of the UK Biobank strategic oversight committee, Chair of the scientific advisory board for the Bradford Health Research Institute public health &#x2018;ActEarly&#x2019; Programme and Chair of the NIHR-BHF partnership working group on maternal cardiovascular health. She does not receive any payment for these activities. The authors whose names are listed immediately below certify that they have no affiliations with or involvement in any organisation or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript: MK, MS, AK, JPP and AL.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>4</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41230535</ArticleId><ArticleId IdType="pmc">PMC12603722</ArticleId><ArticleId IdType="doi">10.1136/bmjph-2025-003264</ArticleId><ArticleId IdType="pii">bmjph-2025-003264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization; 2018.  [10-Jun-2023]. Global status report on alcohol and health 2018.https://apps.who.int/iris/handle/10665/274603 Available. Accessed.</Citation></Reference><Reference><Citation>Popova S, Lange S, Probst C, et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e290&#x2013;9. doi: 10.1016/S2214-109X(17)30021-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(17)30021-9</ArticleId><ArticleId IdType="pubmed">28089487</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccia M, Munch A, Hansen BM, et al. Heavy prenatal alcohol exposure and overall morbidities: a Danish nationwide cohort study from 1996 to 2018. Lancet Public Health. 2023;8:e36&#x2013;46. doi: 10.1016/S2468-2667(22)00289-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00289-4</ArticleId><ArticleId IdType="pubmed">36603909</ArticleId></ArticleIdList></Reference><Reference><Citation>Steane SE, Young SL, Clifton VL, et al. Prenatal alcohol consumption and placental outcomes: a systematic review and meta-analysis of clinical studies. Am J Obstet Gynecol. 2021;225:607. doi: 10.1016/j.ajog.2021.06.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2021.06.078</ArticleId><ArticleId IdType="pubmed">34181895</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Government  . Edinburgh, UK: Scottish Government; 2009.  [11-Jun-2023]. Changing Scotland&#x2019;s relationship with alcohol: a framework for action.https://www.ias.org.uk/uploads/pdf/News%20stories/scotland-alcohol-report0209.pdf Available. accessed.</Citation></Reference><Reference><Citation>Kilian C, Lemp JM, Llamosas-Falc&#xf3;n L, et al. Reducing alcohol use through alcohol control policies in the general population and population subgroups: a systematic review and meta-analysis. eClinicalMedicine . 2023;59:101996. doi: 10.1016/j.eclinm.2023.101996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101996</ArticleId><ArticleId IdType="pmc">PMC10225668</ArticleId><ArticleId IdType="pubmed">37256096</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegfried N, Parry C. Do alcohol control policies work? An umbrella review and quality assessment of systematic reviews of alcohol control interventions (2006 - 2017) PLoS One. 2019;14:e0214865. doi: 10.1371/journal.pone.0214865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0214865</ArticleId><ArticleId IdType="pmc">PMC6457561</ArticleId><ArticleId IdType="pubmed">30969992</ArticleId></ArticleIdList></Reference><Reference><Citation>Fell JC, Scherer M. Estimation of the Potential Effectiveness of Lowering the Blood Alcohol Concentration (BAC) Limit for Driving from 0.08 to 0.05 Grams per Deciliter in the United States. Alcohol Clin Exp Res. 2017;41:2128&#x2013;39. doi: 10.1111/acer.13501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.13501</ArticleId><ArticleId IdType="pmc">PMC5790204</ArticleId><ArticleId IdType="pubmed">29064571</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles L, Mackay D, Richardson E, et al. Evaluating the impact of minimum unit pricing (MUP) on alcohol sales after 3 years of implementation in Scotland: A controlled interrupted time-series study. Addiction. 2024;119:1378&#x2013;86. doi: 10.1111/add.16492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.16492</ArticleId><ArticleId IdType="pubmed">38685192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen B, Lindemann C, Petzina R, et al. The Universal and Primary Prevention of Foetal Alcohol Spectrum Disorders (FASD): A Systematic Review. J Primary Prevent . 2022;43:297&#x2013;316. doi: 10.1007/s10935-021-00658-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10935-021-00658-9</ArticleId><ArticleId IdType="pmc">PMC9114092</ArticleId><ArticleId IdType="pubmed">35286547</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health  UK Chief Medical Officers&#x2019; low risk drinking guidelines. 2016.  [11-Jun-2023]. https://assets.publishing.service.gov.uk/media/5a7f51b4e5274a2e87db5206/summary.pdf Available. Accessed.</Citation></Reference><Reference><Citation>Mamluk L, Edwards HB, Savovi&#x107; J, et al. Low alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently &#x201c;safe&#x201d; levels of alcohol during pregnancy? A systematic review and meta-analyses. BMJ Open. 2017;7:e015410. doi: 10.1136/bmjopen-2016-015410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015410</ArticleId><ArticleId IdType="pmc">PMC5642770</ArticleId><ArticleId IdType="pubmed">28775124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamluk L, Jones T, Ijaz S, et al. Evidence of detrimental effects of prenatal alcohol exposure on offspring birthweight and neurodevelopment from a systematic review of quasi-experimental studies. Int J Epidemiol. 2021;49:1972&#x2013;95. doi: 10.1093/ije/dyz272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz272</ArticleId><ArticleId IdType="pmc">PMC7825937</ArticleId><ArticleId IdType="pubmed">31993631</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . Geneva: WHO; 1992.  [20-Jul-2023]. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines.https://apps.who.int/iris/handle/10665/37958 Available. accessed.</Citation></Reference><Reference><Citation>Elm E von, Altman DG, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806&#x2013;8. doi: 10.1136/bmj.39335.541782.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39335.541782.AD</ArticleId><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Government  The Scottish index of multiple deprivation (SIMD) 2020.  [23-Jun-2023]. https://www.gov.scot/collections/scottish-index-of-multiple-deprivation-2020 Available. Accessed.</Citation></Reference><Reference><Citation>Akaike H. Springer; 1998. Information theory and an extension of the maximum likelihood principle. Selected papers of hirotugu akaike; pp. 199&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4612-1694-0_15</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyndman RJ, Athanasopoulos G, Bergmeir C, et al.  Package &#x2018;forecast,&#x2019;. 2020.  [15-Jul-2023]. https://cran.r-project org/web/packages/forecast/forecast pdf Available. Accessed.</Citation></Reference><Reference><Citation>O&#x2019;Donnell A, Anderson P, Jan&#xe9;-Llopis E, et al. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18. BMJ. 2019;366:l5274. doi: 10.1136/bmj.l5274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l5274</ArticleId><ArticleId IdType="pmc">PMC6759563</ArticleId><ArticleId IdType="pubmed">31554617</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P, O&#x2019;Donnell A, Kaner E, et al. Impact of minimum unit pricing on alcohol purchases in Scotland and Wales: controlled interrupted time series analyses. Lancet Public Health. 2021;6:e557&#x2013;65. doi: 10.1016/S2468-2667(21)00052-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00052-9</ArticleId><ArticleId IdType="pubmed">34058125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckermann AME, Morissette K, Boland L, et al. The effects of alcohol container labels on consumption behaviour, knowledge, and support for labelling: a systematic review. Lancet Public Health. 2024;9:e481&#x2013;94. doi: 10.1016/S2468-2667(24)00097-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(24)00097-5</ArticleId><ArticleId IdType="pubmed">38942559</ArticleId></ArticleIdList></Reference><Reference><Citation>Finken MJJ, van der Steen M, Smeets CCJ, et al. Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications. Endocr Rev. 2018;39:851&#x2013;94. doi: 10.1210/er.2018-00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00083</ArticleId><ArticleId IdType="pubmed">29982551</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra J, Bakker R, Irving H, et al. Dose&#x2013;response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)&#x2014;a systematic review and meta&#x2010;analyses. BJOG. 2011;118:1411&#x2013;21. doi: 10.1111/j.1471-0528.2011.03050.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-0528.2011.03050.x</ArticleId><ArticleId IdType="pmc">PMC3394156</ArticleId><ArticleId IdType="pubmed">21729235</ArticleId></ArticleIdList></Reference><Reference><Citation>Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019:CD004659. doi: 10.1002/14651858.CD004659.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004659.pub3</ArticleId><ArticleId IdType="pubmed">17443552</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas DM, Morgan AM, Deans SJ, et al. Ethanol for preventing preterm birth in threatened preterm labor. Cochrane Database Syst Rev. 2015;2015:CD011445. doi: 10.1002/14651858.CD011445.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011445.pub2</ArticleId><ArticleId IdType="pmc">PMC8944412</ArticleId><ArticleId IdType="pubmed">26544539</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75&#x2013;84. doi: 10.1016/S0140-6736(08)60074-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60074-4</ArticleId><ArticleId IdType="pmc">PMC7134569</ArticleId><ArticleId IdType="pubmed">18177778</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell T, Donath S, Cooper-Stanbury M, et al. Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall. Addiction. 2004;99:1024&#x2013;33. doi: 10.1111/j.1360-0443.2004.00815.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2004.00815.x</ArticleId><ArticleId IdType="pubmed">15265099</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Government  The Scottish health survey. 2023.  [20-Aug-2025]. https://www.gov.scot/binaries/content/documents/govscot/publications/statistics/2024/11/scottish-health-survey-2023-volume-1-main-report/documents/scottish-health-survey-2023-main-report-volume-1/scottish-health-survey-2023-main-report-volume-1/govscot%3Adocument/scottish-health-survey-2023-main-report-volume-1.pdf Available. Accessed.</Citation></Reference><Reference><Citation>Public Health England  Maternity high impact area: reducing the incidence of harms caused bu alcohol in pregnancy.  [20-Aug-2025]. https://assets.publishing.service.gov.uk/media/67efd0e7d065389a655cef9c/Maternity_high_impact_area_4_Reducing_the_incidence_of_harms_caused_by_alcohol_in_pregnancy.pdf Available. Accessed.</Citation></Reference><Reference><Citation>Saxov KR, Strandberg-Larsen K, Pristed SG, et al. Maternal alcohol consumption and the risk of miscarriage in the first and second trimesters: A systematic review and dose-response meta-analysis. Acta Obstet Gynecol Scand. 2023;102:821&#x2013;32. doi: 10.1111/aogs.14566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aogs.14566</ArticleId><ArticleId IdType="pmc">PMC10333669</ArticleId><ArticleId IdType="pubmed">37221907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41229170</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2040-1124</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of diabetes investigation</Title><ISOAbbreviation>J Diabetes Investig</ISOAbbreviation></Journal><ArticleTitle>Dual-center prospective validation of an early second-trimester predictive model integrating BMI trajectories and pathophysiological biomarkers for gestational diabetes risk stratification.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/jdi.70179</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To develop and validate an early second-trimester predictive model integrating body mass index (BMI) trajectories and pathophysiological biomarkers for gestational diabetes mellitus (GDM) risk stratification, with the aim of reducing weight-monitoring frequency while maintaining predictive accuracy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective dual-center cohort study, 1,450 pregnant women (&lt;12&#x2009;weeks gestation) without preexisting diabetes were enrolled from two Beijing maternal-child hospitals. Serial anthropometric (BMI at 6-10, 12-14, 15-19, and 24-28&#x2009;weeks) and metabolic biomarkers (fasting glucose, C-peptide, lipids, uric acid) were analyzed. GDM was diagnosed via 75&#x2009;g OGTT at 24-28&#x2009;weeks. Multivariable logistic regression identified predictors using a 7:3 training-test split. Model performance was assessed by area under the ROC curve (AUC), calibration, and decision curve analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">GDM incidence was 26.1% (378/1,450). Significant weight/BMI disparities emerged as early as 6-10&#x2009;weeks (GDM vs NGT: +2.3&#x2009;kg, P&#x2009;&lt;&#x2009;0.0001), escalating through gestation. The final model incorporated age (OR&#x2009;=&#x2009;1.07/year, 95% CI&#x2009;=&#x2009;1.03-1.11), 12-14-week BMI (OR&#x2009;=&#x2009;1.06/kg/m<sup>2</sup>, 1.01-1.12), fasting glucose (OR&#x2009;=&#x2009;1.86/mmol/L, 1.45-2.40), fasting C-peptide (OR&#x2009;=&#x2009;1.87/ng/mL, 1.28-2.73). The model demonstrated moderate discrimination (training AUC&#x2009;=&#x2009;0.684; testing AUC&#x2009;=&#x2009;0.685) with 63.7-67.2% sensitivity and 59.8-61.4% specificity at the optimal threshold (0.237). Negative predictive values exceeded 82%, enabling effective risk exclusion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This dual-center model pioneers GDM risk stratification by 12-14&#x2009;weeks using clinically accessible metrics, reducing weight-monitoring frequency without compromising prognostic value. While AUC limitations (0.68-0.69) suggest unmeasured contributors, its operational simplicity and robust negative predictive capacity support implementation in resource-constrained settings. The findings redefine antenatal care paradigms by shifting focus to early metabolic dysregulation rather than late diagnostic thresholds.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Junxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Shuoning</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duo</LastName><ForeName>Yanbei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Xiaolin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuemei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Haidian District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Core Facility of Instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory, Haidian District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Xiaorui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiujin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xianchun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Beijing Chaoyang District Maternal and Child Health Care Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ailing</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Core Facility of Instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yingyue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zechun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Weigang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019ZX09734001</GrantID><Agency>Weigang Zhao</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Diabetes Investig</MedlineTA><NlmUniqueID>101520702</NlmUniqueID><ISSNLinking>2040-1116</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BMI trajectories</Keyword><Keyword MajorTopicYN="N">Early prediction model</Keyword><Keyword MajorTopicYN="N">Gestational diabetes mellitus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41229170</ArticleId><ArticleId IdType="doi">10.1111/jdi.70179</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Sweeting A, Hannah W, Backman H, et&#xa0;al. Epidemiology and management of gestational diabetes. Lancet 2024; 404: 175&#x2013;192.</Citation></Reference><Reference><Citation>Committee on Practice Bulletins&#x2014;Obstetrics. American College of Obstetricians and Gynecologists. Practice bulletin no. 190 gestational diabetes mellitus. Obstet Gynecol 2018; 131: e49&#x2013;e64.</Citation></Reference><Reference><Citation>Popova PV, Isakov AO, Rusanova AN, et&#xa0;al. Personalized prediction of glycemic responses to food in women with diet&#x2010;treated gestational diabetes: the role of the gut microbiota. NPJ Biofilms Microbiomes 2025; 11: 25.</Citation></Reference><Reference><Citation>Gao C, Sun X, Lu L, et&#xa0;al. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta&#x2010;analysis. J Diabetes Investig 2019; 10: 154&#x2013;162.</Citation></Reference><Reference><Citation>Zhang J, Fang X, Song Z, et&#xa0;al. Positive association of triglyceride glucose index and gestational diabetes mellitus: a retrospective cohort study. Front Endocrinol 2025; 15: 1475212.</Citation></Reference><Reference><Citation>Han Z, Mulla S, Beyene J, et&#xa0;al. Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta&#x2010;analyses. Int J Epidemiol 2011; 40: 65&#x2013;101.</Citation></Reference><Reference><Citation>Liu P, Xu L, Wang Y, et&#xa0;al. Association between perinatal outcomes and maternal pre&#x2010;pregnancy body mass index. Obes Rev 2016; 17: 1091&#x2013;1102.</Citation></Reference><Reference><Citation>Heslehurst N, Vieira R, Hayes L, et&#xa0;al. Maternal body mass index and post&#x2010;term birth: a systematic review and meta&#x2010;analysis. Obes Rev 2017; 18: 293&#x2013;308.</Citation></Reference><Reference><Citation>Kaseva N, V&#xe4;&#xe4;r&#xe4;sm&#xe4;ki M, Matinolli H&#x2010;M, et&#xa0;al. Pre&#x2010;pregnancy overweight or obesity and gestational diabetes as predictors of body composition in offspring twenty years later: evidence from two birth cohort studies. Int J Obes 2018; 42: 872&#x2013;879.</Citation></Reference><Reference><Citation>Liao Q, Yu T, Chen J, et&#xa0;al. Relationship between maternal pre&#x2010;pregnancy BMI and neonatal birth weight in pregnancies with gestational diabetes mellitus: a retrospective cohort study. Front Med 2025; 11: 1478907.</Citation></Reference><Reference><Citation>Girard C, Zeitlin J, Marlow N, et&#xa0;al. Impact of maternal prepregnancy body mass index on neonatal outcomes following extremely preterm birth. Obesity (Silver Spring) 2025; 33: 599&#x2013;611.</Citation></Reference><Reference><Citation>Sun H, Liu Y, Huang S, et&#xa0;al. Association between pre&#x2010;pregnancy body mass index and maternal and neonatal outcomes of singleton pregnancies after assisted reproductive technology. Front Endocrinol (Lausanne) 2022; 12: 825336.</Citation></Reference><Reference><Citation>Poston L, Caleyachetty R, Cnattingius S, et&#xa0;al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 2016; 4: 1025&#x2013;1036.</Citation></Reference><Reference><Citation>Zheng L, Liao Q, Liu J, et&#xa0;al. Association between pre&#x2010;pregnancy BMI and pregnancy outcomes in women with gestational diabetes: a retrospective cohort study. Pak J Med Sci 2025; 41: 37&#x2013;43.</Citation></Reference><Reference><Citation>Lubrano C, Locati F, Parisi F, et&#xa0;al. Gestational weight gain as a modifiable risk factor in women with extreme pregestational BMI. Nutrients 2025; 17: 736.</Citation></Reference><Reference><Citation>Chen Y, Wan K, Gong Y, et&#xa0;al. Assessing the relationship between pregravid body mass index and risk of adverse maternal pregnancy and neonatal outcomes: prospective data in Southwest China. Sci Rep 2021; 11: 7591.</Citation></Reference><Reference><Citation>Zhu Y, Zheng Q, Pan Y, et&#xa0;al. Association between prepregnancy body mass index or gestational weight gain and adverse pregnancy outcomes among Chinese women with gestational diabetes mellitus: a systematic review and meta&#x2010;analysis. BMJ Open 2024; 14: e075226.</Citation></Reference><Reference><Citation>Zheng Q, Zhu Y, Jiang X, et&#xa0;al. The exploration of optimal gestational weight gain after oral glucose tolerance test for Chinese women with gestational diabetes mellitus. Sci Rep 2024; 14: 1466.</Citation></Reference><Reference><Citation>Miao H, Liang F, Zheng Z, et&#xa0;al. Weight progression and adherence to weight gain target in women with vs. without gestational diabetes: a retrospective cohort study. BMC Pregnancy Childbirth 2023; 23: 513.</Citation></Reference><Reference><Citation>Schoenaker DAJM, de Jersey S, Willcox J, et&#xa0;al. Prevention of gestational diabetes: the role of dietary intake, physical activity, and weight before, during, and between pregnancies. Semin Reprod Med 2020; 38: 352&#x2013;365.</Citation></Reference><Reference><Citation>Hivert MF, White F, Allard C, et&#xa0;al. Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes. Nat Med 2024; 30: 1689&#x2013;1695.</Citation></Reference><Reference><Citation>Olmos&#x2010;Ortiz A, Flores&#x2010;Espinosa P, D&#xed;az L, et&#xa0;al. Immunoendocrine dysregulation during gestational diabetes mellitus: The central role of the placenta. Int J Mol Sci 2021; 22: 8087.</Citation></Reference><Reference><Citation>Hou W, Meng X, Zhao A, et&#xa0;al. Development of multimarker diagnostic models from metabolomics analysis for gestational diabetes mellitus (GDM). Mol Cell Proteomics 2018; 17: 431&#x2013;441.</Citation></Reference><Reference><Citation>Nthavong S, Jatavan P, Tongsong T. Predictive utility of biochemical markers for the diagnosis and prognosis of gestational diabetes mellitus. Int J Mol Sci 2024; 25: 11666.</Citation></Reference><Reference><Citation>Xilifu N, Zhang R, Dai Y, et&#xa0;al. Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis. Reprod Biol Endocrinol 2024; 22: 108.</Citation></Reference><Reference><Citation>Duo Y, Song S, Zhang Y, et&#xa0;al. Relationship between serum uric acid in early pregnancy and gestational diabetes mellitus: a prospective cohort study. Endocrine 2024; 83: 636&#x2013;647.</Citation></Reference><Reference><Citation>Ghasemi A. Uric acid&#x2010;induced pancreatic &#x3b2;&#x2010;cell dysfunction. BMC Endocr Disord 2021; 21(1): 24.</Citation></Reference><Reference><Citation>Dias S, Pheiffer C, Abrahams Y, et&#xa0;al. Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci 2018; 19: 2926.</Citation></Reference><Reference><Citation>Bawah AT, Seini MM, Abaka&#x2010;Yawason A, et&#xa0;al. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus. Lipids Health Dis 2019; 18: 221.</Citation></Reference><Reference><Citation>Liu K, Wang H. Serum adipocytokines and inflammatory cytokines in pregnant women with gestational diabetes mellitus: clinical utility and development of a risk prediction model. Expert Rev Clin Immunol 2025; 21: 369&#x2013;375.</Citation></Reference><Reference><Citation>Sakurai K, Eguchi A, Watanabe M, et&#xa0;al. Exploration of predictive metabolic factors for gestational diabetes mellitus in Japanese women using metabolomic analysis. J Diabetes Investig 2019; 10: 513&#x2013;520.</Citation></Reference><Reference><Citation>Hall CS, Fottrell E, Wilkinson S, et&#xa0;al. Assessing the impact of mHealth interventions in low&#x2010; and middle&#x2010;income countries&#x2010;&#x2010;what has been shown to work? Glob Health Action 2014; 7: 25606.</Citation></Reference><Reference><Citation>Ge X, Peng Y, Tu D. A threshold linear mixed model for identification of treatment&#x2010;sensitive subsets in a clinical trial based on longitudinal outcomes and a continuous covariate. Stat Methods Med Res 2020; 29: 2919&#x2013;2931.</Citation></Reference><Reference><Citation>Gou W, Xiao C, Liang X, et&#xa0;al. Physical activity during pregnancy and preterm birth among women with gestational diabetes. JAMA Netw Open 2024; 7: e2451799.</Citation></Reference><Reference><Citation>Facco FL, Grobman WA, Reid KJ, et&#xa0;al. Objectively measured short sleep duration and later sleep midpoint in pregnancy are associated with a higher risk of gestational diabetes. Am J Obstet Gynecol 2017; 217: 447.e1&#x2013;13.</Citation></Reference><Reference><Citation>Singh K, Ranjani H, Rhodes E, et&#xa0;al. International models of care that address the growing diabetes prevalence in developing countries. Curr Diab Rep 2016; 16: 69.</Citation></Reference><Reference><Citation>Ali U, Cure L, Lewis RK, et&#xa0;al. Examining rurality and social determinants of health among women with GDM: a 15&#x2010;year comprehensive population analysis. BMC Womens Health 2024; 24: 467.</Citation></Reference><Reference><Citation>Arnoriaga&#x2010;Rodriguez M, Melero V, Barabash A, et&#xa0;al. Modifiable risk factors and trends in changes in glucose regulation during the first three years postdelivery: the St Carlos gestational diabetes mellitus prevention cohort. Nutrients 2023; 15: 4995.</Citation></Reference><Reference><Citation>Marshall CJ, Parham L, Hubbard E, et&#xa0;al. Experiences of preconception counseling among pregnant women with preexisting diabetes: opportunities to improve patient&#x2010;centered care. Int J Environ Res Public Health 2023; 20: 2908.</Citation></Reference><Reference><Citation>Zhang J, Cao Q, Mao C, et&#xa0;al. Development and validation of a prediction model for gestational diabetes mellitus risk among women from 8 to 14&#x2009;weeks of gestation in Western China. BMC Pregnancy Childbirth 2025; 25: 385.</Citation></Reference><Reference><Citation>Hashemipour S, Zohal M, Modarresnia L, et&#xa0;al. The yield of early&#x2010;pregnancy homeostasis of model assessment&#x2010;insulin resistance (HOMA&#x2010;IR) for predicting gestational diabetes mellitus in different body mass index and age groups. BMC Pregnancy Childbirth 2023; 23: 822.</Citation></Reference><Reference><Citation>Roverso M, Dogra R, Visentin S, et&#xa0;al. Mass spectrometry&#x2010;based &#x201c;omics&#x201d; technologies for the study of gestational diabetes and the discovery of new biomarkers. Mass Spectrom Rev 2023; 42: 1424&#x2013;1461.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">41228473</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>21</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>29</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Prediction of Gestational Diabetes Mellitus: A Nomogram Model Incorporating Lifestyle, Nutrition and Health Literacy Factors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3400</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu17213400</ELocationID><Abstract><AbstractText><b>Background:</b> Over the past several decades, the prevalence of gestational diabetes mellitus (GDM) has risen markedly worldwide, posing serious threats to both maternal and child health by increasing adverse pregnancy outcomes and long-term metabolic risks. Developing effective risk prediction tools for early detection and intervention has become the most important clinical priority in this field. The current GDM prediction models primarily rely on non-modifiable factors, for example age and body mass index, while modifiable factors such as lifestyle and health literacy, although strongly associated with GDM, have not been fully utilized in risk assessment. This study sought to establish and validate a nomogram prediction model combining modifiable and non-modifiable risk factors, with the goal of identifying high-risk Chinese pregnant women with GDM at an early stage and promoting targeted prevention and personalized prenatal management. <b>Methods:</b> A multicenter study was conducted across 7 maternal health institutions in Southern China (2021-2023), enrolling 806 singleton pregnant women (14-23<sup>+6</sup> weeks). The collected data included sociodemographic, clinical history, and modifiable factors collected through validated questionnaires: dietary quality, physical activity level, sleep quality, and nutrition and health literacy. GDM was diagnosed via 75 g oral glucose tolerance test at 24-28 weeks. Predictive factors were identified through multi-variable logistic regression. A nomogram model was developed (70% modeling group) and validated (30% validation group). Receiver operator characteristic curves, calibration curves, and decision curve analysis were used to evaluate the prediction ability, the degree of calibration, and the clinical benefit of the model, respectively. <b>Results:</b> The finalized risk prediction model included non-modifiable factors such as maternal age, pre-pregnancy weight, and maternal polycystic ovary syndrome, as well as modifiable factors including dietary quality, physical activity level, sleep quality, nutrition and health literacy. The application of the nomogram in the modeling group and the validation groups showed that the model had high stability, favorable predictive ability, good calibration effect and clinical practicality. <b>Conclusions:</b> Overall, the integrated model demonstrates significant clinical utility as it facilitates the prompt identification of individuals at heightened risk and offers actionable targets for personalized interventions. In terms of future implementation, this model can be integrated into prenatal care as a rapid scoring table during early pregnancy consultations or incorporated into mobile health applications. This approach fosters precise prevention strategies for GDM in maternal health by emphasizing nutrition and health literacy, supplemented by coordinated adjustments in diet, physical activity, and sleep.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Minghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Menglu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Zhencheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Laidi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wanyi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Lishan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7732-3073</Identifier><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhixu</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-1633-6313</Identifier><AffiliationInfo><Affiliation>Department of Maternal, Child and Adolescent Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute of Nutrition and Food Science, Nanjing Medical University, Nanjing 211166, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82173503</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2019FY101001</GrantID><Agency>National Program on Basic Research Project of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chinese pregnant women</Keyword><Keyword MajorTopicYN="N">gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">lifestyle</Keyword><Keyword MajorTopicYN="N">nutrition and health literacy</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41228473</ArticleId><ArticleId IdType="doi">10.3390/nu17213400</ArticleId><ArticleId IdType="pii">nu17213400</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">41228433</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>21</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Type 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3360</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu17213360</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: History of gestational diabetes mellitus (GDM) is a strong risk factor in the development of type 2 diabetes (T2D). We sought to examine the association between perceived risk of developing T2D and relevant health behaviors in this population. <b>Methods</b>: We analyzed self-reported survey items and objective electronic health record data of participants in the Gestational diabetes Risk Attenuation for New Diabetes (GRAND) Study, a multisite randomized control trial testing the effectiveness of shared decision-making for women with elevated body mass index (BMI), prediabetes and history of GDM. Data on demographics, health behaviors, and perceived T2D risk were self-reported. We ran four regression models to study the association between women's perceived risk of developing T2D and four key health behaviors: (1) physical activity, (2) consumption of sugar-sweetened beverages, (3) consumption of ultra-processed foods, and (4) consumption of meals prepared outside the home. All models were adjusted for age, race, ethnicity, income, HbA1c, BMI, family history of T2D, and study arm. <b>Results</b>: Our sample included 242 women who on average were 41 years old (&#xb1;6 years) with BMI of 32.7 (&#xb1;6.9 kg/m<sup>2</sup>). Perceived risk of developing T2D was not significantly associated with physical activity, consumption of sugar-sweetened beverages, ultra-processed food consumption, or meals prepared outside of the home. Higher BMI was significantly associated with increased consumption of sugar-sweetened beverages (OR 1.05, 95% CI 1.01-1.10), but not other health behaviors. <b>Conclusions</b>: We found perceived risk of developing T2D was not independently associated with four key health behaviors. Women with GDM are at high risk of developing T2D and may benefit from tailored or more intensive strategies promoting health behavior changes shown to lower T2D risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malone</LastName><ForeName>Allyson</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0003-6837-8480</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tibbe</LastName><ForeName>Tristan D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0003-0684-8304</Identifier><AffiliationInfo><Affiliation>Department of Medicine Statistics Core, UCLA Health, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turk</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duru</LastName><ForeName>Obidiugwu Kenrik</ForeName><Initials>OK</Initials><Identifier Source="ORCID">0000-0001-8825-9460</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisk</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangione</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9475-2275</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Page</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Maternal-Fetal Medicine, Intermountain Health, University of Utah Health, Salt Lake City, UT 84143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Samuel C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Intermountain Health, Murray, UT 84017, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madievsky</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chon</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Felicia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maranon</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krong</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Healthcare Delivery Institute, Office of Research, Intermountain Health, Murray, UT 84107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Healthcare Delivery Institute, Office of Research, Intermountain Health, Murray, UT 84107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Christina S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-1627-3057</Identifier><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, CA 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moin</LastName><ForeName>Tannaz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine-Health Services Research, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology Diseases, Diabetes and Metabolism, Department of Medicine, University of California, Los Angeles, CA 90024, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HSR and CSP NODES, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5R01DK127733</GrantID><Agency>NIH/NIDDK</Agency><Country/></Grant><Grant><GrantID>UL1TR001881</GrantID><Agency>Biomedical Informatics Program (BIP) at UCLA CTSI NIH/NCATS</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes prevention</Keyword><Keyword MajorTopicYN="N">gestational diabetes</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword><Keyword MajorTopicYN="N">physical activity</Keyword><Keyword MajorTopicYN="N">women&#x2019;s health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41228433</ArticleId><ArticleId IdType="doi">10.3390/nu17213360</ArticleId><ArticleId IdType="pii">nu17213360</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>